Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/18451218/ below:

Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung

Affiliations

• ¹ Cancer Biology Program at the Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.

• PMID: 18451218
• DOI: 10.1158/1078-0432.CCR-07-2033

Item in Clipboard

Julien D F Licchesi et al. Clin Cancer Res. 2008.

• ¹ Cancer Biology Program at the Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, USA.

• PMID: 18451218
• DOI: 10.1158/1078-0432.CCR-07-2033

Item in Clipboard

Purpose: According to current models of tumorigenesis, the progression of phenotypic changes culminating in overtly malignant carcinoma is driven by genetic and epigenetic alterations. The recognition of an early form of glandular neoplasia termed atypical adenomatous hyperplasia (AAH), a precursor lesion from which lung adenocarcinomas arise, provides an opportunity for characterizing early epigenetic alterations involved in lung tumorigenesis.

Experimental design: We evaluated AAHs, adjacent normal lung tissue, and synchronous lung adenocarcinomas for promoter hypermethylation of genes implicated in lung tumorigenesis (p16, TIMP3, DAPK, MGMT, RARbeta, RASSF1A, and hTERT).

Results: For individual genes and the number of genes methylated, we observed a significant increase in the frequency of promoter hypermethylation in the histologic progression from normal to AAH, with low-grade or high-grade atypia, and finally to adenocarcinoma (P(trend) </= 0.01). Multifocal AAHs from individual patients had distinct patterns of promoter hypermethylation, suggesting divergent epigenetic field defects. There were statistically significant positive associations for the presence of promoter hypermethylation of individual and multiple genes with advanced histology, with odds ratios between 4.3 and 58.5. p16 conveyed the strongest individual association for promoter hypermethylation when comparing tumor or high-grade AAH to low-grade AAH or normal tissue, with an odds ratio of 45.5 (95% confidence interval, 5.8-360.5).

Conclusion: This study shows epigenetic progression in the earliest stages of glandular neoplasia of the lung and has implications for early lung cancer detection.

PubMed Disclaimer

• Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.

  Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ. Zou XP, et al. Hum Pathol. 2009 Nov;40(11):1534-42. doi: 10.1016/j.humpath.2009.01.029. Epub 2009 Aug 19. Hum Pathol. 2009. PMID: 19695681

• Prognostic implication of aberrant promoter hypermethylation of CpG islands in adenocarcinoma of the lung.

  Kim YT, Park SJ, Lee SH, Kang HJ, Hahn S, Kang CH, Sung SW, Kim JH. Kim YT, et al. J Thorac Cardiovasc Surg. 2005 Nov;130(5):1378. doi: 10.1016/j.jtcvs.2005.06.015. Epub 2005 Oct 13. J Thorac Cardiovasc Surg. 2005. PMID: 16256792

• Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.

  Yokozaki M, Kodama T, Yokose T, Matsumoto T, Mukai K. Yokozaki M, et al. Mod Pathol. 1996 Dec;9(12):1156-64. Mod Pathol. 1996. PMID: 8972475

• Early glandular neoplasia of the lung.

  Westra WH. Westra WH. Respir Res. 2000;1(3):163-9. doi: 10.1186/rr28. Epub 2000 Nov 17. Respir Res. 2000. PMID: 11667981 Free PMC article. Review.

• Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung.

  Mori M, Rao SK, Popper HH, Cagle PT, Fraire AE. Mori M, et al. Mod Pathol. 2001 Feb;14(2):72-84. doi: 10.1038/modpathol.3880259. Mod Pathol. 2001. PMID: 11235908 Review.

• Identification and validation of novel DNA methylation markers for early diagnosis of lung adenocarcinoma.

  Li M, Zhang C, Zhou L, Li S, Cao YJ, Wang L, Xiang R, Shi Y, Piao Y. Li M, et al. Mol Oncol. 2020 Nov;14(11):2744-2758. doi: 10.1002/1878-0261.12767. Epub 2020 Aug 27. Mol Oncol. 2020. PMID: 32688456 Free PMC article.

• Predicting Neoplastic Progression in Barrett's Esophagus.

  Wang JS, Canto MI. Wang JS, et al. Ann Gastroentol Hepatol. 2010 Jun;1(1):1-10. Ann Gastroentol Hepatol. 2010. PMID: 21552467 Free PMC article.

• Do all lung adenocarcinomas follow a stepwise progression?

  Yatabe Y, Borczuk AC, Powell CA. Yatabe Y, et al. Lung Cancer. 2011 Oct;74(1):7-11. doi: 10.1016/j.lungcan.2011.05.021. Epub 2011 Jun 25. Lung Cancer. 2011. PMID: 21705107 Free PMC article. Review.

• Premalignant Progression in the Lung: Knowledge Gaps and Novel Opportunities for Interception of Non-Small Cell Lung Cancer. An Official American Thoracic Society Research Statement.

  Moghaddam SJ, Savai R, Salehi-Rad R, Sengupta S, Kammer MN, Massion P, Beane JE, Ostrin EJ, Priolo C, Tennis MA, Stabile LP, Bauer AK, Sears CR, Szabo E, Rivera MP, Powell CA, Kadara H, Jenkins BJ, Dubinett SM, Houghton AM, Kim CF, Keith RL. Moghaddam SJ, et al. Am J Respir Crit Care Med. 2024 Sep 1;210(5):548-571. doi: 10.1164/rccm.202406-1168ST. Am J Respir Crit Care Med. 2024. PMID: 39115548 Free PMC article. Review.

• Molecular epidemiology of female lung cancer.

  Yim SH, Chung YJ. Yim SH, et al. Cancers (Basel). 2011 Apr 1;3(2):1861-76. doi: 10.3390/cancers3021861. Cancers (Basel). 2011. PMID: 24212786 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3